Search

Search Constraints

You searched for: Author/Creator Kros, Johan M

Search Results

1. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. Issue 6 (June 2021)

2. Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial. Issue 9 (September 2018)

6. Cgnl1, an endothelial junction complex protein, regulates GTPase mediated angiogenesis. Issue 14 (31st August 2017)

7. Circulating angiogenic cells in glioblastoma: toward defining crucial functional differences in CAC-induced neoplastic versus reactive neovascularization. Issue 1 (1st April 2020)

8. CTNI-23. IDH1/2wt ANAPLASTIC GLIOMAS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL: OVERALL SURVIVAL RELATED TO TREATMENT, MGMT STATUS AND MOLECULAR FEATURES OF GLIOBLASTOMA. (9th November 2020)

9. Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups. Issue 1 (31st May 2019)

10. Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups. Issue 1 (31st May 2019)